25 XP   0   0   10

Zhejiang Xianju Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Xianju Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Xianju Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Xianju Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Xianju Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Xianju Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Xianju Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Xianju Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.02
Expected worth in 1 year
¥6.33
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.61
Return On Investment
5.1%

For what price can you sell your share?

Current Price per Share
¥12.09
Expected price per share
¥10.65 - ¥13.40
How sure are you?
50%

1. Valuation of Zhejiang Xianju Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥12.09

Intrinsic Value Per Share

¥2.27 - ¥4.37

Total Value Per Share

¥8.29 - ¥10.39

2. Growth of Zhejiang Xianju Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Xianju Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$822.5m$740.1m$56.3m7.1%

How much money is Zhejiang Xianju Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$20m$26m-$5.9m-29.9%
Net Profit Margin13.6%17.8%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Xianju Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Xianju Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Xianju Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Xianju Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Xianju Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Xianju Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Xianju Pharmaceutical Co Ltd is ¥12.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Xianju Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Xianju Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.02. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Xianju Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.2%0.020.2%0.030.2%0.020.2%0.010.1%
Usd Book Value Change Per Share0.020.1%0.010.1%0.020.2%0.020.2%0.020.1%
Usd Dividend Per Share0.000.0%0.010.1%0.020.2%0.010.1%0.010.1%
Usd Total Gains Per Share0.020.1%0.020.2%0.040.4%0.030.3%0.030.2%
Usd Price Per Share1.29-1.62-1.52-1.62-1.56-
Price to Earnings Ratio15.33-21.57-14.84-21.17-61.72-
Price-to-Total Gains Ratio73.07-80.95-63.32-81.37-129.48-
Price to Book Ratio1.56-2.02-2.03-2.68-4.37-
Price-to-Total Gains Ratio73.07-80.95-63.32-81.37-129.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.669629
Number of shares598
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.020.03
Gains per Quarter (598 shares)12.6219.38
Gains per Year (598 shares)50.4877.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1252540255368
250519049106146
3757614074159224
410010219098212302
5125127240123265380
6150153290147318458
7175178340172371536
8200204390196424614
9225229440221477692
10250255490245530770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%59.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%36.04.00.090.0%50.09.00.084.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%54.00.05.091.5%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%58.01.00.098.3%

Fundamentals of Zhejiang Xianju Pharmaceutical Co Ltd

About Zhejiang Xianju Pharmaceutical Co Ltd

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products. The company was founded in 1972 and is headquartered in Xianju, China.

Fundamental data was last updated by Penke on 2024-05-06 00:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Zhejiang Xianju Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Xianju Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 14.6% means that ¥0.15 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 14.6%. The company is making a huge profit. +2
  • The TTM is 13.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.6%TTM13.6%+0.9%
TTM13.6%YOY17.8%-4.1%
TTM13.6%5Y14.0%-0.4%
5Y14.0%10Y9.9%+4.1%
1.1.2. Return on Assets

Shows how efficient Zhejiang Xianju Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.1% Return on Assets means that Zhejiang Xianju Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 2.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%+0.0%
TTM2.1%YOY2.8%-0.7%
TTM2.1%5Y2.2%-0.1%
5Y2.2%10Y1.6%+0.6%
1.1.3. Return on Equity

Shows how efficient Zhejiang Xianju Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Equity means Zhejiang Xianju Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.5%+0.0%
TTM2.5%YOY3.6%-1.0%
TTM2.5%5Y3.4%-0.8%
5Y3.4%10Y2.7%+0.7%

1.2. Operating Efficiency of Zhejiang Xianju Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Xianju Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Xianju Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.8%-4.8%
TTM4.8%YOY16.8%-12.0%
TTM4.8%5Y13.8%-9.0%
5Y13.8%10Y8.2%+5.6%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Xianju Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are ¥1.29 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 1.290. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.306. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.290TTM1.306-0.017
TTM1.306YOY1.258+0.049
TTM1.3065Y1.265+0.042
5Y1.26510Y0.954+0.310

1.3. Liquidity of Zhejiang Xianju Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Xianju Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.14 means the company has ¥3.14 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 3.143. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.189. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.143TTM3.189-0.046
TTM3.189YOY3.257-0.069
TTM3.1895Y2.506+0.682
5Y2.50610Y1.422+1.084
1.3.2. Quick Ratio

Measures if Zhejiang Xianju Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.58 means the company can pay off ¥0.58 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 0.577. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.631. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.631-0.055
TTM0.631YOY0.887-0.255
TTM0.6315Y0.684-0.052
5Y0.68410Y0.658+0.026

1.4. Solvency of Zhejiang Xianju Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Xianju Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.17 means that Zhejiang Xianju Pharmaceutical Co Ltd assets are financed with 17.1% credit (debt) and the remaining percentage (100% - 17.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 0.171. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.179. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.171TTM0.179-0.008
TTM0.179YOY0.207-0.028
TTM0.1795Y0.313-0.134
5Y0.31310Y0.399-0.086
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Xianju Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 20.8% means that company has ¥0.21 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The MRQ is 0.208. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.220. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.208TTM0.220-0.011
TTM0.220YOY0.264-0.044
TTM0.2205Y0.524-0.304
5Y0.52410Y0.763-0.240

2. Market Valuation of Zhejiang Xianju Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Xianju Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Xianju Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.33 means the investor is paying ¥15.33 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The EOD is 19.785. Based on the earnings, the company is fair priced.
  • The MRQ is 15.333. Based on the earnings, the company is fair priced.
  • The TTM is 21.565. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.785MRQ15.333+4.451
MRQ15.333TTM21.565-6.232
TTM21.565YOY14.840+6.725
TTM21.5655Y21.173+0.392
5Y21.17310Y61.724-40.551
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The EOD is 43.235. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 33.508. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 54.364. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD43.235MRQ33.508+9.727
MRQ33.508TTM54.364-20.856
TTM54.364YOY37.727+16.637
TTM54.3645Y30.312+24.052
5Y30.31210Y39.069-8.757
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Xianju Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Xianju Pharmaceutical Co Ltd:

  • The EOD is 2.008. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.556. Based on the equity, the company is underpriced. +1
  • The TTM is 2.023. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.008MRQ1.556+0.452
MRQ1.556TTM2.023-0.467
TTM2.023YOY2.025-0.002
TTM2.0235Y2.681-0.658
5Y2.68110Y4.368-1.687
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Xianju Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1280.077+66%0.151-15%0.160-20%0.121+6%
Book Value Per Share--6.0215.831+3%5.418+11%4.635+30%3.340+80%
Current Ratio--3.1433.189-1%3.257-4%2.506+25%1.422+121%
Debt To Asset Ratio--0.1710.179-4%0.207-17%0.313-45%0.399-57%
Debt To Equity Ratio--0.2080.220-5%0.264-21%0.524-60%0.763-73%
Dividend Per Share--0.0010.076-99%0.170-100%0.074-99%0.068-99%
Eps--0.1530.147+4%0.188-19%0.150+2%0.097+58%
Free Cash Flow Per Share--0.0700.097-28%0.105-33%0.101-31%0.070-1%
Free Cash Flow To Equity Per Share--0.0700.013+436%-0.139+299%0.017+320%0.059+19%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.372--------
Intrinsic Value_10Y_min--2.267--------
Intrinsic Value_1Y_max--0.386--------
Intrinsic Value_1Y_min--0.274--------
Intrinsic Value_3Y_max--1.199--------
Intrinsic Value_3Y_min--0.788--------
Intrinsic Value_5Y_max--2.060--------
Intrinsic Value_5Y_min--1.258--------
Market Cap11959488353.280+22%9268850775.04011635523718.400-20%10891146961.920-15%11594966313.728-20%11153548424.123-17%
Net Profit Margin--0.1460.136+7%0.178-18%0.140+4%0.099+47%
Operating Margin---0.048-100%0.168-100%0.138-100%0.082-100%
Operating Ratio--1.2901.306-1%1.258+3%1.265+2%0.954+35%
Pb Ratio2.008+22%1.5562.023-23%2.025-23%2.681-42%4.368-64%
Pe Ratio19.785+22%15.33321.565-29%14.840+3%21.173-28%61.724-75%
Price Per Share12.090+22%9.37011.763-20%11.010-15%11.722-20%11.275-17%
Price To Free Cash Flow Ratio43.235+22%33.50854.364-38%37.727-11%30.312+11%39.069-14%
Price To Total Gains Ratio94.279+22%73.06880.950-10%63.325+15%81.367-10%129.475-44%
Quick Ratio--0.5770.631-9%0.887-35%0.684-16%0.658-12%
Return On Assets--0.0210.021+2%0.028-25%0.022-5%0.016+29%
Return On Equity--0.0260.025+0%0.036-28%0.034-24%0.027-6%
Total Gains Per Share--0.1280.153-16%0.321-60%0.235-45%0.189-32%
Usd Book Value--822577350.970796540302.758+3%740147327.630+11%633231453.290+30%456221633.928+80%
Usd Book Value Change Per Share--0.0180.011+66%0.021-15%0.022-20%0.017+6%
Usd Book Value Per Share--0.8320.805+3%0.748+11%0.640+30%0.461+80%
Usd Dividend Per Share--0.0000.010-99%0.023-100%0.010-99%0.009-99%
Usd Eps--0.0210.020+4%0.026-19%0.021+2%0.013+58%
Usd Free Cash Flow--9550087.30813286167.393-28%14304849.648-33%13845905.532-31%8172450.778+17%
Usd Free Cash Flow Per Share--0.0100.013-28%0.014-33%0.014-31%0.010-1%
Usd Free Cash Flow To Equity Per Share--0.0100.002+436%-0.019+299%0.002+320%0.008+19%
Usd Market Cap1651605341.588+22%1280028292.0331606865825.511-20%1504067395.441-15%1601264847.926-20%1540305037.371-17%
Usd Price Per Share1.670+22%1.2941.624-20%1.520-15%1.619-20%1.557-17%
Usd Profit--20869929.26920062250.859+4%26059550.775-20%20275976.988+3%13132613.775+59%
Usd Revenue--143337682.189145145147.604-1%148046091.382-3%143416862.8910%120752901.980+19%
Usd Total Gains Per Share--0.0180.021-16%0.044-60%0.032-45%0.026-32%
 EOD+4 -4MRQTTM+20 -15YOY+11 -245Y+15 -2010Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Xianju Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.785
Price to Book Ratio (EOD)Between0-12.008
Net Profit Margin (MRQ)Greater than00.146
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.577
Current Ratio (MRQ)Greater than13.143
Debt to Asset Ratio (MRQ)Less than10.171
Debt to Equity Ratio (MRQ)Less than10.208
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.021
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Xianju Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose11.850
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,186,669
Total Liabilities1,230,279
Total Stockholder Equity5,907,070
 As reported
Total Liabilities 1,230,279
Total Stockholder Equity+ 5,907,070
Total Assets = 7,186,669

Assets

Total Assets7,186,669
Total Current Assets3,521,008
Long-term Assets3,665,661
Total Current Assets
Cash And Cash Equivalents 1,667,358
Net Receivables 646,244
Inventory 879,777
Other Current Assets 13,316
Total Current Assets  (as reported)3,521,008
Total Current Assets  (calculated)3,206,694
+/- 314,313
Long-term Assets
Property Plant Equipment 2,418,322
Goodwill 592,852
Intangible Assets 166,474
Long-term Assets Other 112,289
Long-term Assets  (as reported)3,665,661
Long-term Assets  (calculated)3,289,937
+/- 375,724

Liabilities & Shareholders' Equity

Total Current Liabilities1,120,244
Long-term Liabilities110,035
Total Stockholder Equity5,907,070
Total Current Liabilities
Short Long Term Debt 1,568
Accounts payable 507,652
Other Current Liabilities 8,499
Total Current Liabilities  (as reported)1,120,244
Total Current Liabilities  (calculated)517,719
+/- 602,525
Long-term Liabilities
Long term Debt 36,690
Capital Lease Obligations Min Short Term Debt7,840
Long-term Liabilities  (as reported)110,035
Long-term Liabilities  (calculated)44,530
+/- 65,505
Total Stockholder Equity
Retained Earnings 2,698,896
Total Stockholder Equity (as reported)5,907,070
Total Stockholder Equity (calculated)2,698,896
+/- 3,208,174
Other
Capital Stock989,205
Common Stock Shares Outstanding 989,205
Net Invested Capital 5,945,329
Net Working Capital 2,400,763
Property Plant and Equipment Gross 2,418,322



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302008-12-312007-12-312006-12-31
> Total Assets 
984,320
1,045,275
1,152,989
1,204,295
1,245,413
1,878,437
1,837,291
1,816,046
1,815,111
1,822,626
1,815,278
2,026,050
2,076,821
2,013,530
2,100,286
2,412,519
2,402,818
2,442,986
2,779,966
2,684,281
2,820,173
2,753,782
2,731,253
2,804,480
2,865,043
2,802,557
2,847,280
2,823,674
2,857,659
3,438,943
3,378,704
3,502,821
3,518,574
3,620,741
3,570,948
4,108,798
4,040,908
5,134,599
5,264,389
5,508,734
5,606,778
5,443,275
5,598,110
5,803,728
5,840,944
5,824,346
5,958,228
6,018,607
6,328,685
6,838,231
6,888,947
6,887,523
6,995,904
6,723,208
6,835,093
6,635,403
6,717,132
6,738,173
6,917,547
6,908,390
7,003,008
6,992,835
7,186,669
7,186,6696,992,8357,003,0086,908,3906,917,5476,738,1736,717,1326,635,4036,835,0936,723,2086,995,9046,887,5236,888,9476,838,2316,328,6856,018,6075,958,2285,824,3465,840,9445,803,7285,598,1105,443,2755,606,7785,508,7345,264,3895,134,5994,040,9084,108,7983,570,9483,620,7413,518,5743,502,8213,378,7043,438,9432,857,6592,823,6742,847,2802,802,5572,865,0432,804,4802,731,2532,753,7822,820,1732,684,2812,779,9662,442,9862,402,8182,412,5192,100,2862,013,5302,076,8212,026,0501,815,2781,822,6261,815,1111,816,0461,837,2911,878,4371,245,4131,204,2951,152,9891,045,275984,320
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,997,336
3,007,926
2,720,836
2,890,298
3,025,214
2,944,767
2,856,529
2,982,438
3,025,070
3,319,614
3,748,789
3,843,966
3,799,069
3,873,942
3,553,607
3,501,209
3,501,209
3,504,793
3,434,294
3,579,331
3,457,678
3,548,178
3,399,871
3,521,008
3,521,0083,399,8713,548,1783,457,6783,579,3313,434,2943,504,7933,501,2093,501,2093,553,6073,873,9423,799,0693,843,9663,748,7893,319,6143,025,0702,982,4382,856,5292,944,7673,025,2142,890,2982,720,8363,007,9262,997,336000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,077,347
1,105,774
892,488
960,980
1,051,753
1,040,025
1,027,947
1,188,759
1,022,410
1,307,704
1,437,627
1,455,508
1,290,521
1,396,819
1,266,966
1,243,983
1,040,141
1,187,631
1,720,466
1,752,919
1,607,531
1,734,898
1,660,044
1,667,358
1,667,3581,660,0441,734,8981,607,5311,752,9191,720,4661,187,6311,040,1411,243,9831,266,9661,396,8191,290,5211,455,5081,437,6271,307,7041,022,4101,188,7591,027,9471,040,0251,051,753960,980892,4881,105,7741,077,347000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,500
0
0
0
0
0
0
0
0
0
0
0
0
0
500,642
500,642
502,958
404,507
0
0
0
0
0
0
000000404,507502,958500,642500,642000000000000051,500000000000000000000000000000000000000000
       Net Receivables 
208,666
242,737
262,991
278,584
328,264
303,189
327,903
346,986
379,691
341,105
395,349
347,206
381,636
316,775
415,268
433,693
483,425
482,548
566,738
603,096
639,240
575,153
677,166
676,710
795,905
736,834
826,915
774,537
898,437
785,910
833,793
834,440
922,330
895,977
995,141
998,648
1,094,890
1,069,791
1,095,959
1,089,289
1,144,742
1,063,040
848,649
918,761
829,544
997,492
994,507
1,130,216
1,154,905
932,951
930,183
1,007,973
937,874
769,898
952,341
952,341
927,453
553,595
629,051
865,634
696,223
551,695
646,244
646,244551,695696,223865,634629,051553,595927,453952,341952,341769,898937,8741,007,973930,183932,9511,154,9051,130,216994,507997,492829,544918,761848,6491,063,0401,144,7421,089,2891,095,9591,069,7911,094,890998,648995,141895,977922,330834,440833,793785,910898,437774,537826,915736,834795,905676,710677,166575,153639,240603,096566,738482,548483,425433,693415,268316,775381,636347,206395,349341,105379,691346,986327,903303,189328,264278,584262,991242,737208,666
       Other Current Assets 
43,106
38,315
35,123
36,245
38,594
36,441
39,968
41,358
49,804
23,904
31,567
46,045
66,961
32,150
34,766
79,220
36,228
28,596
47,126
49,033
61,609
26,806
63,717
56,750
48,092
32,970
60,008
38,408
53,331
46,971
403,487
67,467
417,932
46,704
355,687
78,535
287,932
35,967
215,219
69,191
94,314
104,055
15,858
22,705
29,069
137,288
121,535
138,730
134,072
152,106
653,006
179,589
696,072
127,637
128,528
128,528
138,545
23,918
18,721
98,825
10,603
38,301
13,316
13,31638,30110,60398,82518,72123,918138,545128,528128,528127,637696,072179,589653,006152,106134,072138,730121,535137,28829,06922,70515,858104,05594,31469,191215,21935,967287,93278,535355,68746,704417,93267,467403,48746,97153,33138,40860,00832,97048,09256,75063,71726,80661,60949,03347,12628,59636,22879,22034,76632,15066,96146,04531,56723,90449,80441,35839,96836,44138,59436,24535,12338,31543,106
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,707,812
2,778,514
2,896,176
2,967,816
2,975,790
2,993,537
3,009,071
3,089,442
3,044,981
3,088,454
3,121,962
3,169,601
3,220,012
3,134,194
3,212,339
3,303,879
3,338,216
3,450,712
3,454,830
3,592,964
3,665,661
3,665,6613,592,9643,454,8303,450,7123,338,2163,303,8793,212,3393,134,1943,220,0123,169,6013,121,9623,088,4543,044,9813,089,4423,009,0712,993,5372,975,7902,967,8162,896,1762,778,5142,707,812000000000000000000000000000000000000000000
       Property Plant Equipment 
297,444
328,009
316,817
359,347
312,990
368,578
324,152
376,636
340,604
380,087
351,599
513,318
502,462
721,888
741,511
867,282
890,969
1,011,527
1,001,182
1,057,665
1,030,383
1,186,242
1,054,652
1,086,170
1,101,250
1,073,753
1,066,673
1,067,414
1,064,237
1,090,641
1,089,288
1,119,695
1,127,722
1,197,203
1,193,517
1,193,361
1,203,555
1,363,783
1,407,727
1,462,554
1,519,986
1,623,044
1,626,842
1,673,226
1,792,272
1,879,710
1,890,703
1,907,060
1,940,319
1,925,412
1,913,185
1,941,762
1,975,623
2,013,441
1,950,226
1,950,226
1,972,003
2,038,382
2,071,932
2,109,861
2,120,780
2,256,831
2,418,322
2,418,3222,256,8312,120,7802,109,8612,071,9322,038,3821,972,0031,950,2261,950,2262,013,4411,975,6231,941,7621,913,1851,925,4121,940,3191,907,0601,890,7031,879,7101,792,2721,673,2261,626,8421,623,0441,519,9861,462,5541,407,7271,363,7831,203,5551,193,3611,193,5171,197,2031,127,7221,119,6951,089,2881,090,6411,064,2371,067,4141,066,6731,073,7531,101,2501,086,1701,054,6521,186,2421,030,3831,057,6651,001,1821,011,527890,969867,282741,511721,888502,462513,318351,599380,087340,604376,636324,152368,578312,990359,347316,817328,009297,444
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
602,568
597,587
590,922
618,693
606,043
583,909
603,703
598,822
603,587
603,070
614,824
617,380
619,767
594,883
593,601
581,129
557,574
547,148
541,255
539,772
573,267
578,797
608,345
585,778
606,962
592,852
592,852606,962585,778608,345578,797573,267539,772541,255547,148557,574581,129593,601594,883619,767617,380614,824603,070603,587598,822603,703583,909606,043618,693590,922597,587602,5680000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
146,585
147,803
186,053
196,586
190,305
203,624
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000203,624190,305196,586186,053147,803146,585000000000000000000000000000000000000000
       Intangible Assets 
35,188
56,571
54,800
5,064
53,409
5,299
52,831
4,699
51,948
4,462
51,920
7,799
62,580
3,558
51,570
3,319
50,318
2,210
49,070
1,958
94,597
1,015
93,172
92,504
91,823
95,951
95,387
94,792
94,228
93,907
93,538
102,704
102,677
102,376
101,795
103,889
103,148
834,447
823,607
221,408
223,097
213,286
200,017
116,257
198,167
197,021
193,030
191,153
187,285
183,996
175,838
190,713
184,861
178,403
186,908
181,168
177,361
177,183
172,795
175,124
168,384
166,486
166,474
166,474166,486168,384175,124172,795177,183177,361181,168186,908178,403184,861190,713175,838183,996187,285191,153193,030197,021198,167116,257200,017213,286223,097221,408823,607834,447103,148103,889101,795102,376102,677102,70493,53893,90794,22894,79295,38795,95191,82392,50493,1721,01594,5971,95849,0702,21050,3183,31951,5703,55862,5807,79951,9204,46251,9484,69952,8315,29953,4095,06454,80056,57135,188
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,308
11,230
11,230
14,734
13,319
9,941
1,945,293
10,321
7,737
7,256
7,022
77,283
60,356
92,766
155,128
175,098
167,466
196,272
212,063
234,449
112,289
112,289234,449212,063196,272167,466175,098155,12892,76660,35677,2837,0227,2567,73710,3211,945,2939,94113,31914,73411,23011,23019,308000000000000000000000000000000000000000000
> Total Liabilities 
593,349
644,443
747,439
810,892
828,011
778,280
717,801
764,271
731,967
701,286
674,668
966,350
977,152
860,017
925,370
1,266,275
1,221,729
1,240,375
1,561,801
1,505,148
1,642,012
1,571,760
1,544,582
1,597,972
1,644,994
1,574,613
1,607,248
1,603,227
1,611,583
1,286,417
1,213,229
1,354,539
1,328,891
1,383,729
1,320,399
1,849,606
1,712,531
2,748,639
2,829,274
3,042,967
3,042,362
2,732,961
2,815,657
2,987,029
2,899,334
2,765,742
2,837,214
2,836,428
2,984,506
2,255,881
2,236,058
2,222,156
2,162,369
1,778,316
1,781,605
1,597,252
1,475,892
1,230,731
1,266,369
1,326,387
1,300,040
1,162,789
1,230,279
1,230,2791,162,7891,300,0401,326,3871,266,3691,230,7311,475,8921,597,2521,781,6051,778,3162,162,3692,222,1562,236,0582,255,8812,984,5062,836,4282,837,2142,765,7422,899,3342,987,0292,815,6572,732,9613,042,3623,042,9672,829,2742,748,6391,712,5311,849,6061,320,3991,383,7291,328,8911,354,5391,213,2291,286,4171,611,5831,603,2271,607,2481,574,6131,644,9941,597,9721,544,5821,571,7601,642,0121,505,1481,561,8011,240,3751,221,7291,266,275925,370860,017977,152966,350674,668701,286731,967764,271717,801778,280828,011810,892747,439644,443593,349
   > Total Current Liabilities 
590,681
594,443
697,439
760,891
787,902
778,280
717,801
764,271
731,967
636,286
609,668
901,350
894,302
777,167
834,488
1,131,633
1,050,337
1,125,006
1,430,422
1,329,010
1,436,314
1,340,140
1,356,012
1,425,277
1,473,685
1,403,122
1,452,306
1,445,144
1,452,567
1,160,319
1,149,892
1,296,474
1,285,548
1,341,480
1,279,307
1,601,105
1,464,802
1,602,745
1,592,013
1,834,048
1,748,267
1,606,171
1,704,680
1,828,586
1,653,120
1,747,205
1,860,473
1,992,149
2,045,696
1,618,840
1,598,078
1,716,725
1,739,705
1,390,095
1,247,066
1,247,066
1,128,383
969,067
1,002,202
1,079,200
1,122,894
1,046,910
1,120,244
1,120,2441,046,9101,122,8941,079,2001,002,202969,0671,128,3831,247,0661,247,0661,390,0951,739,7051,716,7251,598,0781,618,8402,045,6961,992,1491,860,4731,747,2051,653,1201,828,5861,704,6801,606,1711,748,2671,834,0481,592,0131,602,7451,464,8021,601,1051,279,3071,341,4801,285,5481,296,4741,149,8921,160,3191,452,5671,445,1441,452,3061,403,1221,473,6851,425,2771,356,0121,340,1401,436,3141,329,0101,430,4221,125,0061,050,3371,131,633834,488777,167894,302901,350609,668636,286731,967764,271717,801778,280787,902760,891697,439594,443590,681
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,913
2,952
4,924
704,734
678,244
678,437
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000678,437678,244704,7344,9242,9524,913000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,913
2,952
4,924
704,734
678,244
678,437
535,298
681,823
631,541
641,328
310,775
346,643
346,890
230,791
65,591
135,499
50,849
75,560
37,399
34,102
40,111
1,017
1,031
1,568
1,5681,0311,01740,11134,10237,39975,56050,849135,49965,591230,791346,890346,643310,775641,328631,541681,823535,298678,437678,244704,7344,9242,9524,913000000000000000000000000000000000000000
       Accounts payable 
90,065
112,843
108,660
138,935
158,165
123,191
116,055
141,820
137,422
145,631
172,415
246,581
244,128
228,417
260,636
355,208
333,560
272,478
321,184
386,224
432,573
353,322
272,228
291,254
325,162
241,505
257,334
298,466
277,997
184,425
212,554
337,564
350,073
354,135
304,748
396,933
416,006
393,320
445,190
646,495
602,146
400,486
495,544
581,113
418,852
362,377
424,939
573,512
544,348
417,721
403,849
492,332
478,103
385,307
437,499
437,499
373,704
354,782
427,682
528,462
524,649
484,506
507,652
507,652484,506524,649528,462427,682354,782373,704437,499437,499385,307478,103492,332403,849417,721544,348573,512424,939362,377418,852581,113495,544400,486602,146646,495445,190393,320416,006396,933304,748354,135350,073337,564212,554184,425277,997298,466257,334241,505325,162291,254272,228353,322432,573386,224321,184272,478333,560355,208260,636228,417244,128246,581172,415145,631137,422141,820116,055123,191158,165138,935108,660112,84390,065
       Other Current Liabilities 
106,816
92,708
74,525
91,259
120,917
109,579
96,731
126,002
123,288
97,566
96,534
122,607
121,982
123,979
115,085
332,227
311,791
345,266
541,826
328,646
316,390
334,076
130,246
108,447
135,784
189,275
171,832
155,628
165,575
216,407
157,940
157,928
181,428
243,554
225,519
238,056
278,354
380,325
348,656
228,640
313,667
372,132
1,862
472,521
2,093
428,497
438,246
406,270
532,541
431,655
507,934
471,052
516,855
410,774
471,743
471,743
573,873
3,896
3,162
350,726
7,799
3,346
8,499
8,4993,3467,799350,7263,1623,896573,873471,743471,743410,774516,855471,052507,934431,655532,541406,270438,246428,4972,093472,5211,862372,132313,667228,640348,656380,325278,354238,056225,519243,554181,428157,928157,940216,407165,575155,628171,832189,275135,784108,447130,246334,076316,390328,646541,826345,266311,791332,227115,085123,979121,982122,60796,53497,566123,288126,00296,731109,579120,91791,25974,52592,708106,816
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,110,977
1,158,444
1,246,214
1,018,537
976,741
844,279
938,811
637,042
637,981
505,430
422,664
388,221
379,164
350,187
347,509
261,664
264,167
247,187
177,146
115,880
110,035
110,035115,880177,146247,187264,167261,664347,509350,187379,164388,221422,664505,430637,981637,042938,811844,279976,7411,018,5371,246,2141,158,4441,110,977000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,913
-2,952
-4,924
-704,734
-678,244
-678,437
0
0
0
0
0
0
0
0
7,494
2,268
2,384
2,485
4,404
4,405
4,251
3,928
9,754
7,840
7,8409,7543,9284,2514,4054,4042,4852,3842,2687,49400000000-678,437-678,244-704,734-4,924-2,952-4,913000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,056,503
1,104,805
1,192,803
960,056
917,105
781,693
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000781,693917,105960,0561,192,8031,104,8051,056,503000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,481
19,036
30,639
32,503
37,265
35,065
17,544
20,093
17,327
16,953
15,834
14,874
14,118
13,432
12,549
11,382
11,382
10,380
0
0
11,081
0
0
0
00011,0810010,38011,38211,38212,54913,43214,11814,87415,83416,95317,32720,09317,54435,06537,26532,50330,63919,03617,481000000000000000000000000000000000000000
> Total Stockholder Equity
362,385
375,527
382,198
374,252
398,415
1,081,016
1,099,899
1,034,450
1,066,834
1,106,192
1,127,888
1,048,942
1,086,263
1,119,174
1,140,938
1,112,706
1,143,835
1,164,604
1,182,493
1,147,835
1,153,077
1,156,996
1,165,068
1,185,504
1,198,269
1,213,676
1,225,374
1,204,818
1,234,914
2,140,207
2,153,829
2,138,076
2,179,785
2,225,428
2,241,895
2,245,692
2,305,419
2,353,268
2,393,755
2,421,211
2,510,793
2,631,669
2,688,013
2,723,306
2,826,442
2,941,525
3,008,771
3,060,378
3,211,085
4,444,932
4,535,758
4,549,287
4,720,174
4,829,228
4,943,442
4,989,080
5,186,090
5,457,449
5,605,000
5,532,853
5,657,625
5,786,121
5,907,070
5,907,0705,786,1215,657,6255,532,8535,605,0005,457,4495,186,0904,989,0804,943,4424,829,2284,720,1744,549,2874,535,7584,444,9323,211,0853,060,3783,008,7712,941,5252,826,4422,723,3062,688,0132,631,6692,510,7932,421,2112,393,7552,353,2682,305,4192,245,6922,241,8952,225,4282,179,7852,138,0762,153,8292,140,2071,234,9141,204,8181,225,3741,213,6761,198,2691,185,5041,165,0681,156,9961,153,0771,147,8351,182,4931,164,6041,143,8351,112,7061,140,9381,119,1741,086,2631,048,9421,127,8881,106,1921,066,8341,034,4501,099,8991,081,016398,415374,252382,198375,527362,385
   Common Stock
256,000
256,000
256,000
256,000
256,000
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
341,400
512,100
512,100
512,100
512,100
512,100
512,100
610,808
610,808
610,808
610,808
610,808
610,808
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
916,212
989,205
989,205
989,205
989,205
989,205
989,205
989,205
989,205
0
0
989,205
0
0
0
000989,20500989,205989,205989,205989,205989,205989,205989,205989,205916,212916,212916,212916,212916,212916,212916,212916,212916,212916,212916,212916,212916,212916,212610,808610,808610,808610,808610,808610,808512,100512,100512,100512,100512,100512,100341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400341,400256,000256,000256,000256,000256,000
   Retained Earnings 
64,856
76,771
76,377
68,430
92,593
109,878
128,761
63,312
95,697
115,973
137,669
58,724
96,045
119,868
141,634
113,402
144,530
155,395
173,286
138,645
142,299
141,035
241,345
261,785
274,557
289,983
301,713
281,166
311,199
345,324
358,915
343,153
384,851
430,430
446,666
450,517
510,290
575,979
616,480
644,309
732,673
822,369
725,375
781,517
898,633
1,173,184
1,240,539
1,286,881
1,440,020
1,586,041
1,696,643
1,711,700
1,896,888
2,053,603
2,236,314
2,236,314
2,434,434
2,319,460
2,452,572
2,664,829
2,494,301
2,547,774
2,698,896
2,698,8962,547,7742,494,3012,664,8292,452,5722,319,4602,434,4342,236,3142,236,3142,053,6031,896,8881,711,7001,696,6431,586,0411,440,0201,286,8811,240,5391,173,184898,633781,517725,375822,369732,673644,309616,480575,979510,290450,517446,666430,430384,851343,153358,915345,324311,199281,166301,713289,983274,557261,785241,345141,035142,299138,645173,286155,395144,530113,402141,634119,86896,04558,724137,669115,97395,69763,312128,761109,87892,59368,43076,37776,77164,856
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,218
681
-1,466
657
-182
227
118
5,384
2,951
68,463
48,875
47,348
33,047
-15,976
-38,947
-38,947
-39,946
0
0
76,101
0
0
0
00076,10100-39,946-38,947-38,947-15,97633,04747,34848,87568,4632,9515,384118227-182657-1,4666811,2180000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,123,419
Cost of Revenue-1,943,124
Gross Profit2,180,2942,180,294
 
Operating Income (+$)
Gross Profit2,180,294
Operating Expense-3,465,307
Operating Income658,112-1,285,012
 
Operating Expense (+$)
Research Development260,996
Selling General Administrative1,112,067
Selling And Marketing Expenses0
Operating Expense3,465,3071,373,063
 
Net Interest Income (+$)
Interest Income38,276
Interest Expense-3,366
Other Finance Cost-3,275
Net Interest Income31,635
 
Pretax Income (+$)
Operating Income658,112
Net Interest Income31,635
Other Non-Operating Income Expenses0
Income Before Tax (EBT)641,681658,112
EBIT - interestExpense = -3,366
563,083
566,450
Interest Expense3,366
Earnings Before Interest and Taxes (EBIT)0645,047
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax641,681
Tax Provision-79,562
Net Income From Continuing Ops562,118562,118
Net Income563,083
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-31,635
 

Technical Analysis of Zhejiang Xianju Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Xianju Pharmaceutical Co Ltd. The general trend of Zhejiang Xianju Pharmaceutical Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Xianju Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Xianju Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.25 < 13.05 < 13.40.

The bearish price targets are: 11.22 > 11.00 > 10.65.

Tweet this
Zhejiang Xianju Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Xianju Pharmaceutical Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Xianju Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Xianju Pharmaceutical Co Ltd. The current adx is .

Zhejiang Xianju Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Xianju Pharmaceutical Co Ltd.

Zhejiang Xianju Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Xianju Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Xianju Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Zhejiang Xianju Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Xianju Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose11.850
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Xianju Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Xianju Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Xianju Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Xianju Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Xianju Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Xianju Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Xianju Pharmaceutical Co Ltd in your mailbox!